Quarter
Charts

TG THERAPEUTICS, INC.

TGTX

CIK 0001001316 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$193M
↑+78.0% +$84Mvs FY2024 (Q4)
Operating Income
$50M
↑+71.2% +$21Mvs FY2024 (Q4)
Net Income
$23M
↑+18.1% +$4Mvs FY2024 (Q4)
Gross Profit
$154M
↑+66.4% +$62Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
82/100
  • Profitability
    66ROIC 18.1% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 4.10 (above 1.5 = solid)
  • Leverage
    81D/E 0.38 (under 0.5 = conservative)
  • Efficiency
    42Asset Turnover 0.75x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +78.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 26.2% · trend +9.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$214K
investment in PP&E
Stock buybacks (TTM)
$91M
share count reduction
Stock-based comp (TTM)
$65M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.06B
everything owned
Total liabilities
$415M
everything owed
Stockholders' equity
$648M
shareholder claim
Net debt
$166M
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+78.0% +$84M
$193M
Net Income↑+18.1% +$4M
$23M
Free Cash Flow↑+93400.0% +$20M
$20M
Operating Margin↓-1.0pts
26.2%

Drill down

TGTX Sankey

See TG THERAPEUTICS, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

TGTX Charts

67 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

TGTX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics